Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
Formally established in June 2022, the Hong Kong University of Science and Technology (Guangzhou)(HKUST(GZ)) is a cooperatively-run higher education institution between the Chinese mainland and the
-
[Research areas] The information processing mechanisms of living organisms, including humans, are expected to bring about new breakthroughs in information communication systems. To achieve this, it
-
, Materials Science, Energy Science, Energy Engineering, Optics, Computer Engineering, Integrated Circuits, Information Engineering, Robotics, Network Science, Artificial Intelligence, Financial Engineering
-
APPLICATION CLOSING DATE: June 14th, 2025 Human Technopole (HT) is an interdisciplinary life science research institute, created and supported by the Italian Government, with the aim of developing
-
December 2025, in the México City branch of the Institute. UNAM is México's leading university and is home to some of the most prominent research institutions in Latin America. The IM boasts over 90 full
-
nominations and applications for the position of Susan and Bruce Worster Dean of Mathematical, Life, and Physical Sciences (MLPS). UCSB is ranked #8 globally in interdisciplinary science by Times Higher
-
APPLICATION CLOSING DATE: June 30th, 2025 Human Technopole (HT) is an interdisciplinary life science research institute, created and supported by the Italian Government, with the aim of developing
-
the field of Applied Mathematics, with an expected starting date early 2026, in the Cuernavaca branch of the Institute in the state of Morelos, Mexico. UNAM is Mexico's leading university and is home to some
-
an expected starting date in early 2026, in the Cuernavaca branch of the Institute in the state of Morelos, Mexico. UNAM is Mexico's leading university and is home to some of the most prominent research
-
About This Role: The Biogen West Coast Hub (WCH) is focused on transforming the lives of patients with severe immune mediated diseases by developing novel targeted therapies with outsized clinical